መነሻ › Multiple Myeloma › ሚኔሶታ › Rochester
በRochester፣ MN ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች
ለMultiple Myeloma የሚደረጉ 24 ጥናቶች በRochester እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
ተሳታዮችን በመፈለግ ላይ
- Mayo Clinic in Rochester, Rochester
SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Mayo Clinic in Rochester, Rochester
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic, Rochester
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic Rochester, Rochester
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic, Rochester
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Mayo Clinic Rochester, Rochester
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Mayo Clinic Hospital Rochester /ID# 277886, Rochester
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic in Rochester, Rochester
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mayo Clinic in Rochester, Minnesota, Rochester
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic Rochester, Rochester
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mayo Clinic in Rochester, Rochester
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic in Rochester, Rochester
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic - Transplant Center - Rochester, Rochester
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Rochester
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mayo Clinic - Minnesota, Rochester
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic - Rochester /ID# 251164, Rochester
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic, Rochester
Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Mayo Clinic in Rochester, Rochester
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mayo Clinic in Rochester, Rochester
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Mayo Clinic in Rochester, Rochester
Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma
ተሳታዮችን በመፈለግ ላይ
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Mayo Clinic, Rochester
Family Study of Lymphoproliferative Disorders
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Mayo Clinic, Rochester
በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች
- New York City, NY60 ጥናቶች
- Boston, MA42 ጥናቶች
- Atlanta, GA41 ጥናቶች
- Houston, TX38 ጥናቶች
- Durham, NC37 ጥናቶች
- Nashville, TN32 ጥናቶች
- Denver, CO27 ጥናቶች
- St. Louis, MO24 ጥናቶች
- Columbus, OH24 ጥናቶች
- Baldwin Park, CA23 ጥናቶች
- Chicago, IL22 ጥናቶች
- Seattle, WA22 ጥናቶች
በRochester ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር42 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር37 ጥናቶች
- Metastatic Cancer31 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)30 ጥናቶች
- የኮሎሬክታል ካንሰር29 ጥናቶች
- የእንቁላል ካንሰር29 ጥናቶች
- የፕሮስቴት ካንሰር22 ጥናቶች
- የልብ ድካም22 ጥናቶች
- የፓንክሪያስ ካንሰር22 ጥናቶች
- የሳንባ ካንሰር20 ጥናቶች
- የኤንዶሜትሪየም ካንሰር20 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ19 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።